Arizona Commerce Authority Accepting Applications For 2025 Arizona Innovation Challenge

The Fall 2025 cohort will focus on SaaS startups

“With the prominent growth of the software market globally and in Arizona, we’re excited to support SaaS-focused startups through this year’s Arizona Innovation Challenge,” said Sandra Watson, President and CEO of the Arizona Commerce Authority. “We’re grateful to our Arizona venture capitalist partners for their collaboration and look forward to seeing the exciting startups in this year’s competition.”

Continue reading

AdvaMed is Celebrating 50 Years of Medtech Milestones

As we celebrate the 50th anniversary of AdvaMed, the Medtech Association, we recognize the critical role the medtech industry has played – and always will play – in transforming people’s lives. As the current Administration launches it’s “Make America Healthy Again” initiative, it’s important that we remember that the medtech industry has been making America healthy again since its inception. The story of medtech is the most powerful story in health care and it really is a story as old as toolmaking itself. It is the story of getting people back to good health. Back to “normal.” Back to playing with their grandchildren. Back to moving, walking, and even seeing again. Back to life. Continue reading

2025 Award for Leadership in Personalized Medicine to be Awarded to George Poste, DVM, PhD

PMC, the Personalized Medicine Coalition, announced that George Poste, DVM, PhD, Regents Professor and Del E. Webb Chair in Health Innovation and Chief Scientist, Complex Adaptive Systems Initiative at Arizona State University, will receive the 2025 Award for Leadership in Personalized Medicine at this year’s Personalized Medicine Conference, to be held November 13–14 at the Ritz Carlton, Laguna Niguel, in Dana Point, California. This award recognizes Dr. Poste’s substantial multi-decade contributions to the advancement of personalized medicine and his enduring impact on science, technology, and policy.Continue reading

GT Medical Technologies Completes Final Close of Company’s Oversubscribed $53 Million Series D Equity Financing to Advance Commercial Treatment for Patients with Operable Brain Tumors

July 15, 2025 /PRNewswire/ — GT Medical Technologies, Inc., a medical device company dedicated to improving the lives of patients with brain tumors, today announced the company has completed the close of its oversubscribed $53 million Series D equity financing.Continue reading

Waters and BD’s Biosciences & Diagnostic Solutions Business to Combine, Creating a Life Science and Diagnostics Leader Focused on Regulated, High-Volume Testing

  • Strong strategic fit that increases presence in multiple high-growth adjacencies and offers immediate commercial impact from Waters’ proven execution model
  • Doubles Waters’ total addressable market to approximately $40 billion, with 5-7% annual growth
  • Creates a combined company with pro forma expected 2025 sales of approximately $6.5 billion and adjusted EBITDA of approximately $2.0 billion
  • Increases annual recurring revenue to over 70% with over 80% of revenue coming from iconic market-leading brands
  • Anticipate approximately $345 million in annualized EBITDA synergies by 2030, including $200 million of cost synergies by year three, and $290 million of revenue synergies by year five
  • Delivers an industry-leading financial outlook with mid-to-high single-digit revenue growth, approximately 500 basis points of adjusted operating margin expansion, and mid-teens annualized adjusted EPS growth expected over five years
  • Transaction expected to be accretive to adjusted EPS in the first year

Continue reading